(Q24202926)

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Comparison of mild stimulation and conventional stimulation in ART outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Development, pharmacology and clinical experience with clomiphene citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and in

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

A randomized study comparing IVF in the unstimulated cycle with IVF following clomiphene citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Increasing the gonadotrophin dose in the course of an in vitro fertilization cycle does not rectify an initial poor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Modern use of clomiphene citrate in induction of ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Friendly IVF: the way of the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Controlled ovarian hyperstimulation regimens in assisted reproductive technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Mild ovarian stimulation for IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Efficacy of nafarelin in assisted reproductive technology: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

Comparison of two clomiphene citrate dosage regimens for follicular recruitment in an in vitro fertilization program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

The effect of time of initiation of clomiphene citrate on multiple follicle development for human in vitro fertilization and embryo replacement procedures

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Single-dose pharmacokinetics of clomiphene citrate in normal volunteers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Randomized, prospective trial of leuprolide acetate and conventional superovulation in first cycles of in vitro fertilization and gamete intrafallopian transfer.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Correlation of endometrial histology, morphometry, and ultrasound appearance after different stimulation protocols for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

The effect of ethinyl estradiol on endometrial thickness and uterine volume during ovulation induction by clomiphene citrate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Should gonadotropin-releasing hormone down-regulation therapy be routine in in vitro fertilization?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Luteal phase consequences of low-dose gonadotropin-releasing hormone agonist therapy in nonluteal-supported in vitro fertilization cycles.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Time to revolutionize ovarian stimulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

A comparison of the effects on follicular development between clomiphene citrate, its two separate isomers and spontaneous cycles

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Human preimplantation embryo cryopreservation: selected aspects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Pregnancy rates after transfer of embryos obtained from different stimulation protocols and frozen at either pronucleate or multicellular stages

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Outcome of in-vitro fertilization and embryo transfer after different regimens of ovarian stimulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

The use of the GnRH analogue buserelin for IVF--does it improve fertility?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021

Cyclic clomiphene citrate treatment lowers cytosol estrogen and progestin receptor concentrations in the endometrium of postmenopausal women on estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008528.PUB2

7 January 2021